Table 4.
Regression estimates
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
---|---|---|---|---|---|---|---|---|---|
ALL vs AML | .07 (.25) | 1.32 (.36) | .50 (.23) | .45 (.38) | .12 (.30) | .90 (.31) | .58 (.22) | ||
Age1 | −.25 (.16) | −.68 (.28) | −.49 (.32) | −.45 (.26) | |||||
Age2 | .27 (.20) | .33 (.23) | .51 (.59) | .01 (.24) | .72 (.21) | ||||
FM | −.20 (.28) | −.57 (.39) | |||||||
PBSCT vs BMT | .09 (.22) | .01 (.29) | .28 (.30) | −.12 (.66) | −.17 (.38) | .55 (.35) | |||
ALLxPBSCT | .46 (.23) | .92 (.43) | |||||||
AMLxPBSCT | −.33 (.30) | ||||||||
AMLxBMT | −.30 (.22) | −.50 (.43) | |||||||
DxCr | .12 (.08) | .45 (.16) | .22 (.12) | .13 (.14) | |||||
CrTx | −.21 (.07) | −.26 (.09) | −.33 (.15) | −.24 (.17) | −.10 (.12) | ||||
prioir AGVHD | .72 (.30) | .72 (.20) | |||||||
Age1xPBSCT | −.44 (.34) | ||||||||
Age1xBMT | −.57 (.33) | .70 (.60) | −.88 (.35) | −.64 (.34) | |||||
Age2xPBSCT | −.28 (.25) | .13 (.37) | |||||||
Age2xBMT | −.37 (.24) | .60 (.88) | |||||||
Age0xPBSCT | −.27 (.26) | .40 (.31) | |||||||
AMLxPBSCTxAge2 | .25 (.22) | ||||||||
Age1xALL | .61 (.27) | −.87 (.48) | −.60 (.42) | ||||||
Age2xALL | .57 (.30) | −.97 (.47) | |||||||
FMxALL | .63 (.27) | ||||||||
FMxAML | .64 (.17) | .81 (.45) | |||||||
FMxPBSCT | .42 (.18) | .44 (.25) | |||||||
FXALL | −.25 (.19) | ||||||||
FxAML | −.19 (.14) |
Columns: 1 = Tx → AGVHD; 2 = Tx → CGVHD; 3 = Tx → Relapse; 4 = Tx → Death 5 = AGVHD → CGVHD; 6 = AGVHD → Relapse; 7 = AGVHD → Death; 8 = CGVHD → Relapse; 9 = CGVHD → Death.
Variable names: Age0: age in the (29.5, 42, 5] range, Age1 = age ≤ 29.5 years, Age2 = age > 42.5 years; F = female donor transplant; FM = female donor to male recipient vs other sexmatch transplant.